Hangzhou Diagens Biotechnology Co., Ltd.

Market Cap: N/A
Industry: Medical Specialties
ISIN: CNE100007JC7

HKD

288.80

-41.2 (-12.48%)

Jul 17

HKG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hangzhou Diagens Biotechnology Co., Ltd.

Why is Hangzhou Diagens Biotechnology Co., Ltd. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

74.80%

EBIT Growth (5y)

-54.12%

EBIT to Interest (avg)

-30.53

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

149.17

EV to EBIT

-314.53

EV to EBITDA

-364.38

EV to Capital Employed

207.43

EV to Sales

154.12

PEG Ratio

Dividend Yield

ROCE (Latest)

-65.95%

ROE (Latest)

-39.63%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

KST

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend